Literature DB >> 15933820

Convection enhanced delivery for the treatment of malignant gliomas: symposium review.

Michael A Vogelbaum1.   

Abstract

In January 2003 a symposium was held to discuss the current state of progress and future challenges for the recently described technique of convection enhanced delivery (CED). The focus of the CED symposium was on the potential use of this novel drug delivery technology to enhance the delivery of chemotherapy to malignant brain tumors. The international panel of invited speakers included individuals who had a significant role in pioneering the concept of CED, were actively pursuing new areas of investigation into the uses of CED and/or who were directing the first clinical trials using CED in patients with malignant brain tumors. Topics covered included the physiology of the blood brain barrier, basic principles of CED, application of CED to the treatment of brain tumors, and research models that have been developed to further refine the technique of CED. Each speaker's talk has been abstracted and a list of relevant references has been compiled.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15933820     DOI: 10.1007/s11060-004-2243-8

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  19 in total

Review 1.  The blood-brain and blood-tumor barriers: a review of strategies for increasing drug delivery.

Authors:  D R Groothuis
Journal:  Neuro Oncol       Date:  2000-01       Impact factor: 12.300

2.  Successful and safe perfusion of the primate brainstem: in vivo magnetic resonance imaging of macromolecular distribution during infusion.

Authors:  Russell R Lonser; Stuart Walbridge; Kayhan Garmestani; John A Butman; Hugh A Walters; Alexander O Vortmeyer; Paul F Morrison; Martin W Brechbiel; Edward H Oldfield
Journal:  J Neurosurg       Date:  2002-10       Impact factor: 5.115

3.  Intraparenchymal drug delivery via positive-pressure infusion: experimental and modeling studies of poroelasticity in brain phantom gels.

Authors:  Zhi-Jian Chen; William C Broaddus; Raju R Viswanathan; Raghu Raghavan; George T Gillies
Journal:  IEEE Trans Biomed Eng       Date:  2002-02       Impact factor: 4.538

4.  Convection-enhanced delivery of macromolecules in the brain.

Authors:  R H Bobo; D W Laske; A Akbasak; P F Morrison; R L Dedrick; E H Oldfield
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-15       Impact factor: 11.205

5.  Intracerebral clysis in a rat glioma model.

Authors:  J N Bruce; A Falavigna; J P Johnson; J S Hall; B D Birch; J T Yoon; E X Wu; R L Fine; A T Parsa
Journal:  Neurosurgery       Date:  2000-03       Impact factor: 4.654

6.  Interleukin-13 receptor alpha chain: a novel tumor-associated transmembrane protein in primary explants of human malignant gliomas.

Authors:  B H Joshi; G E Plautz; R K Puri
Journal:  Cancer Res       Date:  2000-03-01       Impact factor: 12.701

7.  Safety and efficacy of convection-enhanced delivery of gemcitabine or carboplatin in a malignant glioma model in rats.

Authors:  Jeffrey W Degen; Stuart Walbridge; Alexander O Vortmeyer; Edward H Oldfield; Russell R Lonser
Journal:  J Neurosurg       Date:  2003-11       Impact factor: 5.115

8.  Progress report of a Phase I study of the intracerebral microinfusion of a recombinant chimeric protein composed of transforming growth factor (TGF)-alpha and a mutated form of the Pseudomonas exotoxin termed PE-38 (TP-38) for the treatment of malignant brain tumors.

Authors:  John H Sampson; Gamal Akabani; Gary E Archer; Darell D Bigner; Mitchel S Berger; Allan H Friedman; Henry S Friedman; James E Herndon; Sandeep Kunwar; Steve Marcus; Roger E McLendon; Alison Paolino; Kara Penne; James Provenzale; Jennifer Quinn; David A Reardon; Jeremy Rich; Timothy Stenzel; Sandra Tourt-Uhlig; Carol Wikstrand; Terence Wong; Roger Williams; Fan Yuan; Michael R Zalutsky; Ira Pastan
Journal:  J Neurooncol       Date:  2003-10       Impact factor: 4.130

9.  Interleukin-13 receptor as a unique target for anti-glioblastoma therapy.

Authors:  S R Husain; B H Joshi; R K Puri
Journal:  Int J Cancer       Date:  2001-04-15       Impact factor: 7.316

10.  Targeting of interleukin-13 receptor on human renal cell carcinoma cells by a recombinant chimeric protein composed of interleukin-13 and a truncated form of Pseudomonas exotoxin A (PE38QQR).

Authors:  R K Puri; P Leland; N I Obiri; S R Husain; R J Kreitman; G P Haas; I Pastan; W Debinski
Journal:  Blood       Date:  1996-05-15       Impact factor: 25.476

View more
  22 in total

Review 1.  Novel delivery strategies for glioblastoma.

Authors:  Jiangbing Zhou; Kofi-Buaku Atsina; Benjamin T Himes; Garth W Strohbehn; W Mark Saltzman
Journal:  Cancer J       Date:  2012 Jan-Feb       Impact factor: 3.360

Review 2.  Emerging treatments and gene expression profiling in high-risk medulloblastoma.

Authors:  Iacopo Sardi; Duccio Cavalieri; Maura Massimino
Journal:  Paediatr Drugs       Date:  2007       Impact factor: 3.022

3.  High intra-abdominal pressure enhances the penetration and antitumor effect of intraperitoneal cisplatin on experimental peritoneal carcinomatosis.

Authors:  Philippe Esquis; David Consolo; Guy Magnin; Philippe Pointaire; Philippe Moretto; Maria Dolores Ynsa; Jean-Luc Beltramo; Carole Drogoul; Michel Simonet; Laurent Benoit; Patrick Rat; Bruno Chauffert
Journal:  Ann Surg       Date:  2006-07       Impact factor: 12.969

Review 4.  Convection enhanced delivery for treating brain tumors and selected neurological disorders: symposium review.

Authors:  Michael A Vogelbaum
Journal:  J Neurooncol       Date:  2007-01-04       Impact factor: 4.130

5.  Convection-enhanced delivery of Ls-TPT enables an effective, continuous, low-dose chemotherapy against malignant glioma xenograft model.

Authors:  Ryuta Saito; Michal T Krauze; Charles O Noble; Daryl C Drummond; Dmitri B Kirpotin; Mitchel S Berger; John W Park; Krystof S Bankiewicz
Journal:  Neuro Oncol       Date:  2006-05-24       Impact factor: 12.300

6.  Metallofullerene-based nanoplatform for brain tumor brachytherapy and longitudinal imaging in a murine orthotopic xenograft model.

Authors:  Michael D Shultz; John D Wilson; Christine E Fuller; Jianyuan Zhang; Harry C Dorn; Panos P Fatouros
Journal:  Radiology       Date:  2011-08-03       Impact factor: 11.105

7.  Dilation and degradation of the brain extracellular matrix enhances penetration of infused polymer nanoparticles.

Authors:  Keith B Neeves; Andrew J Sawyer; Conor P Foley; W Mark Saltzman; William L Olbricht
Journal:  Brain Res       Date:  2007-08-29       Impact factor: 3.252

Review 8.  Novel drug delivery strategies in neuro-oncology.

Authors:  Dani S Bidros; Michael A Vogelbaum
Journal:  Neurotherapeutics       Date:  2009-07       Impact factor: 7.620

9.  Metallofullerene-nanoplatform-delivered interstitial brachytherapy improved survival in a murine model of glioblastoma multiforme.

Authors:  John D Wilson; William C Broaddus; Harry C Dorn; Panos P Fatouros; Charles E Chalfant; Michael D Shultz
Journal:  Bioconjug Chem       Date:  2012-08-21       Impact factor: 4.774

10.  In vivo evaluation of intracellular drug-nanocarriers infused into intracranial tumours by convection-enhanced delivery: distribution and radiosensitisation efficacy.

Authors:  Sandrine Vinchon-Petit; Delphine Jarnet; Archibald Paillard; Jean-Pierre Benoit; Emmanuel Garcion; Philippe Menei
Journal:  J Neurooncol       Date:  2009-09-22       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.